Cargando…

Management of Late Relapses in Metastatic Testicular Germ Cell Tumors: Still a Challenge

Detalles Bibliográficos
Autor principal:	Heidenreich, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Opinion: Open Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317867/ https://www.ncbi.nlm.nih.gov/pubmed/34337541 http://dx.doi.org/10.1016/j.euros.2021.05.010

Ejemplares similares

Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
por: Wenzel, Mike, et al.
Publicado: (2022)

Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
por: McKay, Rana R.
Publicado: (2022)

Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
por: Kartolo, Adi, et al.
Publicado: (2021)

Teratomatous Elements in Orchiectomy Specimens Are Associated with a Reduced Relapse-Free Survival in Metastasized Testicular Germ Cell Tumors
por: Paffenholz, Pia, et al.
Publicado: (2022)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting
por: Martínez-Piñeiro, Luis
Publicado: (2022)

Late relapsing germ cell tumors with elevated tumor markers
por: Che, Yue, et al.
Publicado: (2021)

Radical Resection of a Late-Relapsed Testicular Germ Cell Tumour: Hepatectomy, Cavotomy, and Thrombectomy
por: Ní Leidhin, C., et al.
Publicado: (2014)

The Decision to Surgically Resect Recurrent Renal Cell Carcinoma: More Evidence that Careful Case Selection by Surgeons Is Associated with Better Survival
por: Russo, Paul
Publicado: (2023)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022)

Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour
por: Jay, Alexander P.M., et al.
Publicado: (2021)

Metastasectomy as optimal treatment for late relapsing solitary brain metastasis from testicular germ cell tumor: a case report
por: Iida, Keitaro, et al.
Publicado: (2014)

Late and Rapid Relapse in Mediastinum from Testicular Germ Cell Tumor Stage I Over 13 Years after Surgery
por: Fukushima, Toshirou, et al.
Publicado: (2019)

Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report
por: Tobiume, Motoi, et al.
Publicado: (2021)

Management of poor-prognosis testicular germ cell tumors
por: Khurana, Kiranpreet, et al.
Publicado: (2010)

Lower Urinary Tract Symptoms: A Unique Platform for Urologists’ Fundamental Role in Overall Health
por: Monaghan, Thomas F., et al.
Publicado: (2020)

Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022)

Re-envisioning Patient Education and Public Awareness of Urological Cancers at the Time of the COVID-19 Pandemic
por: Pecoraro, Alessio, et al.
Publicado: (2022)

Prehabilitation Programs Before Radical Prostatectomy: An Interesting Approach that Merits Further Evaluation
por: Isbarn, Hendrik
Publicado: (2020)

Orphaned Side-effects After Robot-assisted Radical Prostatectomy: Is the Retzius-sparing Approach Superior to the Standard Approach or Are the Data Just Not Mature Enough?
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
por: Pomykala, Kelsey L., et al.
Publicado: (2022)

Early or Delayed Radical Cystectomy for High-risk Non–muscle-invasive Bladder Cancer: A Hard Dilemma to Solve
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

A Precision Urodynamic Diagnosis is Essential for Successful Treatment of Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2022)

Sex-specific Augmentation of Treatment Responses in Bladder Cancer
por: Chang, Kevin, et al.
Publicado: (2022)

Defining the Mycobiome in Bladder Cancer
por: Mercier, Benjamin D., et al.
Publicado: (2022)

The Metaverse in Urology: Ready for Prime Time. The ESUT, ERUS, EULIS, and ESU Perspective
por: Checcucci, Enrico, et al.
Publicado: (2022)

Evolution and Implications of the Novel CAMUS Reporting and Classification System: From Rationale to End Product
por: Soliman, Christopher, et al.
Publicado: (2023)

Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer
por: Supiot, Stéphane, et al.
Publicado: (2023)

Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?
por: Rouvière, Olivier, et al.
Publicado: (2022)

Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)

Challenge Based Innovation (CBI) ER, Italy
por: Olofsson, Simon
Publicado: (2019)

Challenge Based Innovation (CBI) A3
por: Poulaillon, Jimmy
Publicado: (2022)

Challenge Based Innovation (CBI) Gala Day
por: Marcelloni, Claudia
Publicado: (2015)

Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
por: Lobo, João, et al.
Publicado: (2020)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Award ceremony of the Mining the Future® challenge-based competition
por: Cavazza, Marina
Publicado: (2022)

Late Relapse and Follow-up Protocols in Testicular Germ Cell Tumours: The Edinburgh Cancer Centre Experience and Review of the Literature
por: Detti, Beatrice, et al.
Publicado: (2008)

RCA Grand Challenge with CERN Champions Design Thinking and Innovation
por: Olofsson, Simon
Publicado: (2019)

Development of CNS-type Primitive Neuroectodermal Tumor in Metastatic Testicular Mixed Germ Cell Tumor
por: Odisho, Anobel Y., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qr4nerqd3isdled8vm1fhho0rl